| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.56B | -10.7% |
| R&D Expense | $60.0M | +107.9% |
| SG&A Expense | $375.5M | -8.7% |
| Operating Income | -$169.8M | +57.0% |
| Interest Expense | $98.8M | +10.3% |
| Pre-tax Income | -$252.3M | +41.6% |
| Income Tax | -$34.2M | -174.0% |
| Net Income | -$218.1M | +54.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $204.2M | -84.0% |
| Short-term Investments | $417.7M | +0.0% |
| Inventory | $151.0M | -9.7% |
| Current Assets | $742.2M | -65.3% |
| Total Assets | $3.47B | -33.2% |
| Current Liabilities | $440.0M | -40.7% |
| Long-term Debt | $1.54B | +3.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$248.4M | -154.9% |
| Capital Expenditures | $205.3M | +8.0% |
| Investing Cash Flow | $209.5M | +22.3% |
| Financing Cash Flow | -$1.03B | — |
| Free Cash Flow | -$453.7M | -272.9% |
| Total Liabilities |
| $3.08B |
| -12.5% |
| Stockholders' Equity | $338.4M | -79.0% |